Idaho First Bank Reports Quarterly

New Post Public Reply Private Reply Replies (0) Message Board

Apr 12, 2013 at 10:31 AM

Idaho First Bank Reports Quarterly Results

MCCALL, ID--(Marketwired - Apr 11, 2013) - Today Idaho First Bank (OTCQB: IDFB) reported financial results for the first quarter of 2013. The Bank reported net income of $106,000 for the first quarter of 2013, compared to net income of $23,000 in the same quarter last year. The quarterly net income for the quarter was close to the record quarterly income of $118,000 reported in the fourth quarter of 2012.

Compared to the prior year, the Bank achieved a 10% increase in net interest income. This was driven by average loan growth of 5% and an improving net interest margin. Mortgage banking income also contributed to the improved results. Mortgage banking income was almost three times the amount received last year.

During the first quarter of 2013, the Bank received additional capital of $1.3 million as part of a private placement offering began in 2012. Mr. Mark Miller, Chairman of the Board, stated, "The Board and Senior Management had significant participation in the offering and their investment represented 65% of the new capital."

Nonperforming assets were $1.3 million at March 31, 2013, a decrease of 51% from the prior year. The allowance for loan losses was 1.37% of loans at March 31 and 133% of nonperforming loans. Mr. Lovell commented, "We are cautiously optimistic about the improving trends in our portfolio. We continue to closely monitor the performance of our loan portfolio and aggressively take action as problems arise."

Stockholders' equity was $6.4 million at March 31, 2013, or 8% of assets. Book value was 57 cents per share, two cents less than a year ago. There was slight dilution from the new offering at 42 cents per share.

Idaho First Bank is a state-chartered commercial bank that opened for business in October 2005. Its headquarters are located in McCall, Idaho, with a loan production office in downtown Boise.

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"). Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected. These risks and uncertainties include, but are not limited to, economic conditions, the regulatory environment, loan concentrations, vendors, employees, technology, competition, and interest rates. Readers are cautioned not to place undue reliance on the forward-looking statements. Idaho First Bank has no obligation to publicly update the forward-looking statements after the date of this release. This statement is included for the express purpose of invoking PSLRA's safe harbor provisions.


Idaho First Bank
Financial Highlights (unaudited)
(Dollars in thousands, except per share)

For the quarter ended March 31:			2013			2012			Change
	Net interest income		$	771		$	698		$	73		10	%
	Provision for loan losses			130			115			15		13	%
	Mortgage banking income			658			226			432		191	%
	Other noninterest income			77			56			21		38	%
	Noninterest expenses			1,270			842			428		51	%

		Net income		106			23			83		361	%

At March 31:			2013			2012			Change
	Loans		$	68,195		$	66,109		$	2,086		3	%
	Allowance for loan losses			934			874			60		7	%
	Assets			82,460			76,519			5,941		8	%
	Deposits			73,694			69,402			4,292		6	%
	Stockholders' equity			6,382			4,730			1,652		35	%

	Nonaccrual loans			698			824			(126	)	-15	%
	Accruing loans more than 90 days past due			5			1,032			(1,027	)	-100	%
	Other real estate owned			633			887			(254	)	-29	%

		Total nonperforming assets		1,336			2,743			(1,407	)	-51	%

	Book value per share			0.57			0.59			(0.02	)	-3	%
	Shares outstanding			11,277,155			7,999,932			3,277,223		41	%

	Allowance to loans			1.37	%		1.32	%
	Allowance to nonperforming loans			133	%		47	%
	Nonperforming loans to total loans			1.03	%		2.81	%

Averages for the quarter ended March 31:			2013			2012			Change
	Loans		$	67,918		$	64,689		$	3,229		5	%
	Earning assets			80,068			73,853			6,215		8	%
	Assets			83,181			77,144			6,037		8	%
	Deposits			75,540			69,907			5,633		8	%
	Stockholders' equity			5,274			4,707			567		12	%

	Loans to deposits			90	%		93	%
	Net interest margin			3.91	%		3.80	%

Idaho First Bank

Quarterly Financial Highlights (unaudited)

(Dollars in thousands)

Income Statement

Q1 2013

Q4 2012

Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Japan's RWE Market Transformation: TXP's Insightful Whitepaper

Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...

Xi Jinping's Vision for China's Financial Evolution

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Curaleaf Eyes Aurora Amid Alternative from Organigram

Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...

PRIMA Invests £10M to Propel CC Forum's Global Reach

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Pyramid Pharma Takes On 13th Blood Cancer Therapy Product

Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...

Class Action Targets Coastal Financial Over Missteps

New Crosshairs on Coastal Financial Corporation Man, it's another day and yet another fiasco in the corporate world. Late-breaking news from the trenches alerts us that Coastal Financial Corporation is in the legal spotlight. Yeah, you heard me right. We're talking about NASDAQ:CCB, the darlings turned defendants courtesy of recent allegations that could rock their stock....

Atlas-SSI Expands Grip in Water Control Space

Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...

Cloud Software Group Amends $2B Cash Tender Offer

Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...

Differentia Bio's AI: Transforming Drug Development Dynamics

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Multiconsult's Q3 2026 Results: A Gradual Rebound

Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...